Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

GenMark

GenMark is a medical device firm that develops and commercializes multiplex molecular diagnostic testing systems for the healthcare industry. Read more

118 Followers on Owler
118 Followers on Owler
118 Followers on Owler
118 Followers on Owler

GenMark

GenMark is a medical device firm that develops and commercializes multiplex molecular diagnostic testing systems for the healthcare industry. Read more

Scott Mendel's photo - President & CEO of GenMark

President & CEO

Scott Mendel

CEO Approval Rating

85/100

Founded:

2010

Status:

PublicAcquisition Pending from F. Hoffmann-La Roche Ltd.NASDAQGNMK

SIC Code:

8000 NAICS listing »

5047 NAICS listing »

Website:

Annual Revenue
Employees
Sector
Biotechnology
Headquarters

GENMARK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in GenMark's competitive set are BioFire Diagnostics, Luminex, Cepheid, T2 Biosystems, Accelerate Diagnostics, Exagen, Daktari Diagnostics, Inc., Crescendo Bioscience, ARUP. Together they have raised over 1.3B between their estimated 58.5K employees. GenMark has 477 employees and is ranked 6th among it's top 10 competitors. The top 10 competitors average 3,930.

BioFire Diagnostics is one of GenMark's top competitors. BioFire Diagnostics was founded in 1990 in Salt Lake City, Utah. Like GenMark, BioFire Diagnostics also operates in the Biotechnology industry. BioFire Diagnostics generates $1.1B more revenue than GenMark.

Luminex is a top competitor of GenMark. Luminex was founded in 1995, and is headquartered in Austin, Texas. Like GenMark, Luminex also competes in the Biotechnology field. Luminex generates $245.8M more revenue vs. GenMark.

Cepheid is seen as one of GenMark's top competitors. Cepheid is headquartered in Sunnyvale, California, and was founded in 1996. Like GenMark, Cepheid also operates in the Biotechnology field. Cepheid generates 1,165% the revenue of GenMark.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Exagen a competitor of GenMark?

I don't know

Trending News for GenMark and GenMark's Competitors

May 6, 2021

Associated Press News

Luminex: Q1 Earnings Snapshot

AUSTIN, Texas (AP) _ Luminex Corp. (LMNX) on Wednesday reported first-quarter profit of $9.1 million.... See more »

May 6, 2021

MarketScreener

Accelerate Diagnostics : First Quarter 2021 Earnings Results Conference Call

(marketscreener.com) First Quarter 2021 Earnings Results Conference Call May 04, 2021 Accelerate Diag... See more »

May 4, 2021

The Business Journals: Greensboro/Winston-Salem/High Point

LabCorp acquires autoimmune testing business from Myriad Genetics

"We've always said that acquiring local laboratories or hospital laboratories or regional laboratorie... See more »

GenMark Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$171.6M

GenMark's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 876.1M. Over the last four quarters, GenMark's revenue has grown by 29.3%. Specifically, in Q4 2020's revenue was $50.1M; in Q3 2020, it was $42.6M; in Q2 2020, it was $40.1M; in Q1 2020, GenMark's revenue was $38.7M.

GenMark Acquisitions

No recent acquisitions found related to GenMark

GenMark Funding History

Since GenMark was founded in 2010, it has participated in 1 round of funding. In total GenMark has raised $27.6M. GenMark's funding round was on May 2010 for a total of $27.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
May 2010
$27.6M

Total Funding: $27.6M

Since GenMark was founded in 2010, it has participated in 1 round of funding. In total GenMark has raised $27.6M. GenMark's funding round was on May 2010 for a total of $27.6M

GenMark Investments

No recent investments found related to GenMark

GenMark News

March 31, 2021Benzinga

Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized sto... See more »
March 26, 2021Post Online Media

Roche commences tender offer for all shares of GenMark Diagnostics for $24.05 per share in cash

Roche announced that it has commenced a cash tender offer for all of the outstanding shares of common... See more »
March 25, 2021CompanyNews HQ

Roche commences tender offer for all shares of GenMark Diagnostics, Inc. for $24.05 per share in cash

Basel, 25 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cas... See more »
March 21, 2021San Diego Business Journal

GenMark Bought for $1.8 Billion

BIOTECH: Roche Purchases Diagnostic Co.... See more »
March 20, 2021MarketScreener

Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK

(marketscreener.com) NEW YORK, March 19, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing p... See more »
March 18, 2021Clinical Lab Products

Roche Signs Definitive Merger Agreement with GenMark Diagnostics

"Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions ... See more »
March 17, 2021Global Legal Chronicle

Roche's $1.8 Billion Acquisition of GenMark Diagnostics

Sidley Austin LLP and DLA Piper LLP advised Roche on the deal. Roche (SIX: RO, ROG; OTCQX: RHHBY) and... See more »

GenMark Press Releases

November 5, 2020GlobeNewswire

GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) ("GenMar... See more »
October 9, 2020GlobalNewswire

GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020

Third Quarter 2020 Revenue Expected to Represent Approximately 104% Year-Over-Year Growth Third Quart... See more »
July 29, 2020GlobeNewswire

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leadin... See more »
June 16, 2020GlobeNewswire

GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health

Largest health system in eastern North Carolina turns to ePlex® platform for fast results on SARS-CoV... See more »
May 11, 2020GlobeNewswire

GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) ("GenMark... See more »
February 10, 2020GlobeNewswire

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020

CARLSBAD, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today an... See more »
February 10, 2020GlobalNewswire

GenMark Diagnostics Announces CEO and Chairman Transition

CARLSBAD, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leadi... See more »

GenMark Videos

July 19, 2019GenMark Vimeo Channel

"ePlex BCID Overview" on VIMEO

Cast: GenMark Dx... See more »
June 28, 2019GenMark Vimeo Channel

"The ePlex® Blood Culture Identification Panels_ Designed to Improve Patient Care and Clinical Outcome" on VIMEO

Cast: GenMark Dx... See more »
June 28, 2019GenMark Vimeo Channel

"How Rapid Diagnostics Can Supercharge Antimicrobial Stewardship Programs" on VIMEO

Cast: GenMark Dx... See more »
January 31, 2019GenMark Vimeo Channel

"The ePlex Blood Culture Identification Panels_ Designed to Improve Patient Care and Clinical Outcome" on VIMEO

Webinar presented on 1.34.2019Cast: GenMark Dx... See more »
November 26, 2018GenMark Vimeo Channel

"The Only Test for Rapid, Routine Blood Culture Identification" on VIMEO

Cast: GenMark Dx... See more »

Social Media

GenMark Headquarters

5964 La Place Court

Carlsbad, California92008

760-448-4300

Driving Directions »

Trending Companies

GenMark Summary

ABOUT

Overview

GenMark is a medical device firm that develops and commercializes multiplex molecular diagnostic testing systems for the healthcare industry. GenMark was founded in 2010. GenMark's headquarters is located in Carlsbad, California, USA 92008. It has rai...

CEO

GenMark's President & CEO, Scott Mendel, currently has an approval rating of 85%. GenMark's primary competitors are BioFire Diagnostics, Luminex & Cepheid.

Website

genmarkdx.com

Frequently Asked Questions about GenMark

  1. When was GenMark founded?

    GenMark was founded in 2010

  2. Who is GenMark's CEO?

    GenMark's CEO is Scott Mendel

  3. How much revenue does GenMark generate?

    GenMark generates $171.6M in revenue

  4. How much funding does GenMark have?

    GenMark has historically raised $27.6M in funding

  1. Where is GenMark's headquarters?

    GenMark's headquarters is in Carlsbad California, USA

  2. How many employees does GenMark have?

    GenMark has 477 employees

  3. What sector does GenMark operate in?

    GenMark is in Biotechnology

  4. Who are GenMark's competitors?

    GenMark's top competitors are BioFire Diagnostics, Luminex, Cepheid
Stay up-to-date with the latest news on GenMark

© 2021 Owler, Inc.